Yahoo Finance 
Global Particle Therapy Market Research Report 2022
Global Particle Therapy Market
Dublin, July 21, 2022 (GLOBE NEWSWIRE) -- The "Particle Therapy Market Research Report" has been added to ResearchAndMarkets.com's offering.
The particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.
Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.
However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region.
Treatment Application accounted for the largest share in the particle therapy market by application type
Based on applications, the particle therapy market has been segmented into treatment and research applications. In 2021, the treatment applications segment is projected to account for the dominant share of 94.4% of the particle therapy market. Increasing government initiatives aimed at equipping or upgrading hospitals with newer and advanced radiotherapy systems.
Proton Therapy accounted for the largest share in the particle therapy market by type
On the basis of type, the particle therapy market is segmented into proton therapy and heavy ion therapy. The proton therapy segment is expected to account for the largest share (85.7%) of the market in 2021.
Factors such as the high dose of radiation, shorter treatment time, a high degree of precision, and lower side effects as compared to conventional photon therapies using traditional X-rays.
Based on product, cyclotrons accounted for the largest share in the particle therapy market
Based on product, the particle therapy products market is further segmented into cyclotrons, synchrotrons, and synchrocyclotrons. In 2021, the cyclotrons segment is expected to account for a share of 71.4% of the particle therapy market; this segment is projected to grow at a CAGR of 6.7% during the forecast period.
Advantages offered by cyclotrons over other accelerators and the development of technologically advanced systems are the major factors pushing the development of this market segment.
Asia Pacific segment accounted for the largest share in the particle therapy market by Region
The Asia Pacific market is expected to account for the largest market share in 2021 and is also projected to witness the highest growth rate during the forecast period.
The Asia Pacific region is expected to offer significant growth opportunities for players operating in the particle therapy market owing to the increasing healthcare expenditure and growing initiatives to promote the use of advanced particle therapy technologies in the Asia Pacific countries.
Key Market Players
Prominent players in the particle therapy market include IBA Worldwide (EU), Hitachi, Ltd. (Japan), Varian Medical Systems, Inc. (US), Provision Healthcare, LLC (US), Optivus Proton Therapy, Inc. (US), and Protom International, Inc. (US).
Premium Insights
Increasing Cancer Prevalence to Drive Market Growth
Asia-Pacific to Register Highest CAGR During Forecast Period
Proton Therapy to Account for Largest Share of Asia-Pacific Market in 2021
China to Register Highest Revenue Growth During Forecast Period
Developing Markets to Register Higher Growth Rate During Forecast Period
Market Dynamics
Drivers
Advantages Offered by Particle Therapy Over Photon Therapy
Growing Global Prevalence of Cancer
Growing Adoption of Particle Therapy in Clinical Trials
Increasing Number of Particle Therapy Centers Worldwide
Rising Technological Advancements
Restraints
Infrastructural Challenges in Healthcare Facilities
Affordability and Accessibility of Treatments
Unfavorable Reimbursement Policies and Limited Insurance Coverage for Particle Therapy
Opportunities
Growing Adoption of Particle Therapy in Emerging Markets
Rising Healthcare Expenditure Across Developing Countries
Challenges
Difficulties in Visualizing Tumors During Particle Therapy Procedures
Increasing Risk of Radiation Exposure
COVID-19 Impact on Economic Scenario in Particle Therapy Market
Ecosystem Analysis
Pricing Analysis
Supply Chain Analysis
Patent Analysis
Patent Publication Trends for Particle Therapy Market
Top Applicants (Companies) for Particle Therapy Patents
Jurisdiction Analysis: Top Applicants (Countries) for Patents in Particle Therapy Market
Company Profiles
Key Players
IBA Worldwide
Varian Medical Systems, Inc.
Hitachi Ltd.
Mevion Medical Systems
Sumitomo Heavy Industries Ltd.
Provision Healthcare, LLC
Toshiba Medical Systems Corporation
Optivus Proton Therapy, Inc.
Protom International, Inc.
Advanced Oncotherapy plc.
Other Players
Danfysik A/S
P-Curea
Ptw Freiburg GmbH
For more information about this report visit https://www.researchandmarkets.com/r/duajuf
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
